脂溢性皮炎的发病机制及治疗研究进展

doi:10.35541/cjd.20240175

Abstract

Abstract: 【Abstract】 Seborrheic dermatitis is a chronic, recurrent, and inflammatory skin disease. Its etiology is intricately related to skin microecological imbalance, dysregulated lipid metabolism, impaired skin barrier function, abnormal immune responses, and genetic predispositions. In recent years, several novel therapeutic approaches have emerged, such as topical phosphodiesterase 4 inhibitors, Janus kinase inhibitors, physical interventions, and chemical peeling, providing more options for the treatment of seborrheic dermatitis. This review summarizes the latest research progress in the pathogenesis and treatment of seborrheic dermatitis.

Key words: Dermatitis, seborrheic, Therapeutics, Pathogenesis, Skin microecology

Wang Di, Zhang Ruijun, Kang Yuying. Pathogenesis and treatment of seborrheic dermatitis[J]. Chinese Journal of Dermatology, 2025, 58(1): 89-92.doi:10.35541/cjd.20240175

References ［43］

［1］	Lin Q, Panchamukhi A, Li P, et al. Malassezia and Staphylococcus dominate scalp microbiome for seborrheic dermatitis［J］. Bioprocess Biosyst Eng, 2021,44（5）:965⁃975. doi: 10.1007/s00449⁃020⁃02333⁃5.
［2］	King A, Tan MG, Kirshen C, et al. Isotretinoin for the management of moderate⁃to⁃severe seborrheic dermatitis: a systematic review［J］. J Am Acad Dermatol. 2023;89（5）:1063⁃1066. doi:10.1016/j.jaad.2023.07.010.
［3］	Gomes TF, Calado R, Matos AL, et al. Contact allergy to antifungals: results of a 12⁃year retrospective study［J］. Contact Dermatitis, 2022,86（6）:539⁃543. doi: 10.1111/cod.14076.
［4］	Vysochanska V, Koval G. Malassezia colonization correlates with the severity of seborrheic dermatitis［J］. Wiad Lek, 2023,76（6）:1371⁃1377. doi: 10.36740/WLek202306107.
［5］	Tao R, Wang R, Wan Z, et al. Ketoconazole 2% cream alters the skin fungal microbiome in seborrhoeic dermatitis: a cohort study［J］. Clin Exp Dermatol, 2022,47（6）:1088⁃1096. doi: 10.1111/ced.15115.
［6］	Li J, Feng Y, Liu C, et al. Presence of Malassezia hyphae is correlated with pathogenesis of seborrheic dermatitis［J］. Microbiol Spectr, 2022,10（1）:e0116921. doi: 10.1128/spectrum. 01169⁃21.
［7］	Sanders M, Nijsten T, Verlouw J, et al. Composition of cutaneous bacterial microbiome in seborrheic dermatitis patients: a cross⁃sectional study［J/OL］. PLoS One, 2021,16（5）:e0251136. doi: 10.1371/journal.pone.0251136.
［8］	Tanaka A, Cho O, Saito C, et al. Comprehensive pyrosequencing analysis of the bacterial microbiota of the skin of patients with seborrheic dermatitis［J］. Microbiol Immunol, 2016,60（8）:521⁃526. doi: 10.1111/1348⁃0421.12398.
［9］	Yu R, Lin Q, Zhai Y, et al. Recombinant human thymosin beta⁃4 （rhTβ4） improved scalp condition and microbiome homeostasis in seborrheic dermatitis［J］. Microb Biotechnol, 2021,14（5）:2152⁃2163. doi: 10.1111/1751⁃7915.13897.
［10］	Loing E, Lamarque E, Borel M. New targets in the battle against dandruff［J］. J Cosmet Sci, 2017,68（1）:107⁃113.
［11］	Suchonwanit P, Triyangkulsri K, Ploydaeng M, et al. Assessing biophysical and physiological profiles of scalp seborrheic dermatitis in the Thai population［J］. Biomed Res Int, 2019,2019:5128376. doi: 10.1155/2019/5128376.
［12］	Ugochukwu I, Rhimi W, Chebil W, et al. Part 2: understanding the role of Malassezia spp. in skin disorders: pathogenesis of Malassezia associated skin infections［J］. Expert Rev Anti Infect Ther, 2023,21（11）:1245⁃1257. doi: 10.1080/14787210.2023. 2274500.
［13］	Rousel J, Nădăban A, Saghari M, et al. Lesional skin of seborrheic dermatitis patients is characterized by skin barrier dysfunction and correlating alterations in the stratum corneum ceramide composition［J］. Exp Dermatol, 2024,33（1）:e14952. doi: 10.1111/exd.14952.
［14］	Tao R, Li R, Wang R. Skin microbiome alterations in seborrheic dermatitis and dandruff: a systematic review［J］. Exp Dermatol, 2021,30（10）:1546⁃1553. doi: 10.1111/exd.14450.
［15］	Mahlangeni GM, Tod BM, Jordaan HF, et al. Clinicopathological features of seborrheic⁃like dermatitis in HIV⁃infected adults: a single institutional descriptive cross⁃sectional study［J］. Am J Dermatopathol, 2021,43（1）:27⁃34. doi: 10.1097/DAD.00000000 00001670.
［16］	Trznadel⁃Grodzka E, Błaszkowski M, Rotsztejn H. Investigations of seborrheic dermatitis. Part I. The role of selected cytokines in the pathogenesis of seborrheic dermatitis［J］. Postepy Hig Med Dosw （Online）, 2012,66:843⁃847. doi: 10.5604/17322693.101 9642.
［17］	Faergemann J, Bergbrant IM, Dohsé M, et al. Seborrhoeic dermatitis and Pityrosporum （Malassezia） folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry［J］. Br J Dermatol, 2001,144（3）:549⁃556. doi: 10.1046/j.1365⁃2133.2001.04082.x.
［18］	Park HR, Oh JH, Lee YJ, et al. Inflammasome⁃mediated inflammation by Malassezia in human keratinocytes: a comparative analysis with different strains［J］. Mycoses, 2021,64（3）:292⁃299. doi: 10.1111/myc.13214.
［19］	Zouboulis CC. The sebaceous gland［J］. Hautarzt, 2010,61（6）:467⁃468, 4704, 476⁃477. doi: 10.1007/s00105⁃009⁃1894⁃y.
［20］	Ozgul A, Altunisik N, Turkmen D, et al. The relationship between seborrheic dermatitis and body composition parameters［J］. North Clin Istanb, 2023,10（2）:271⁃276. doi: 10.14744/nci. 2022.08068.
［21］	Karakadze MA, Hirt PA, Wikramanayake TC. The genetic basis of seborrhoeic dermatitis: a review［J］. J Eur Acad Dermatol Venereol, 2018,32（4）:529⁃536. doi: 10.1111/jdv.14704.
［22］	Fayad AA, El Gayed EMA, Bazid HAS, et al. Evaluation of the role of ACT1 gene polymorphism in seborrheic dermatitis: a case⁃control study［J］. Menoufia Medical Journal, 2022,35（2）:451⁃457. doi: 10.4103/mmj.mmj_190_21.
［23］	Bentivegna K, Adalsteinsson JA, Chang MW. Oral candidiasis and seborrheic dermatitis in an 8⁃year⁃old female with a heterozygous variant of the IL⁃17RC gene［J］. Pediatr Dermatol, 2023,40（6）:1145⁃1146. doi: 10.1111/pde.15343.
［24］	Kim H, Yun JW, Baek G, et al. Differential microRNA profiles in elderly males with seborrheic dermatitis［J］. Sci Rep, 2022,12（1）:21241. doi: 10.1038/s41598⁃022⁃24383⁃3.
［25］	Tomic S, Kuric I, Kuric TG, et al. Seborrheic dermatitis is related to motor symptoms in Parkinson's disease［J］. J Clin Neurol, 2022,18（6）:628⁃634. doi: 10.3988/jcn.2022.18.6.628.
［26］	Rork JF, McCormack L, Lal K, et al. Dermatologic conditions in Down syndrome: a single⁃center retrospective chart review［J］. Pediatr Dermatol, 2020,37（5）:811⁃816. doi: 10.1111/pde.14214.
［27］	Tosun M, Yasak Güner R, Akyol M. Investigation of the relationship between inflammatory blood parameters and seborrheic dermatitis［J］. J Cosmet Dermatol, 2022,21（10）:5111⁃5115. doi: 10.1111/jocd.14984.
［28］	Jahan I, Islam MR, Islam MR, et al. Altered serum elements, antioxidants, MDA, and immunoglobulins are associated with an increased risk of seborrheic dermatitis［J］. Heliyon, 2021,7（3）:e06621. doi: 10.1016/j.heliyon.2021.e06621.
［29］	Akbaş A, Kılınç F, Şener S, et al. Vitamin D levels in patients with seborrheic dermatitis［J］. Rev Assoc Med Bras （1992）, 2023,69（7）:e20230022. doi: 10.1590/1806⁃9282.20230022.
［30］	Lancar R, Missy P, Dupuy A, et al. Risk factors for seborrhoeic dermatitis flares: case⁃control and case⁃crossover study［J］. Acta Derm Venereol, 2020,100（17）:adv00292. doi: 10.2340/000155 55⁃3661.
［31］	Ozgul A, Altunisik N, Turkmen D, et al. The relationship between seborrheic dermatitis and body composition parameters［J］. North Clin Istanb, 2023,10（2）:271⁃276. doi: 10.14744/nci. 2022.08068.
［32］	Akbulut TO, Suslu H, Atci T. Is the frequency of seborrheic dermatitis related to climate parameters?［J］. Sisli Etfal Hastan Tip Bul, 2022,56（1）:91⁃95. doi: 10.14744/SEMB.2021.67503.
［33］	Blauvelt A, Draelos ZD, Stein Gold L, et al. Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: a randomized, double⁃blinded, vehicle⁃controlled, phase 3 trial［J］. J Am Acad Dermatol, 2024,90（5）:986⁃993. doi: 10.1016/j.jaad.2023.12.065.
［34］	Kapoor R, Shome D, Doshi K, et al. A newer approach in the treatment of seborrheic dermatitis with QR678® and QR678 Neo®⁃a prospective pilot study［J］. J Cosmet Dermatol, 2023,22（11）:3078⁃3087. doi: 10.1111/jocd.15957.
［35］	Pope E, Kowalski E, Tausk F. Topical ruxolitinib in the treatment of refractory facial seborrheic dermatitis［J］. JAAD Case Rep, 2022,24:59⁃60. doi: 10.1016/j.jdcr.2022.04.003.
［36］	Tsai WH, Fang YT, Huang TY, et al. Heat⁃killed Lacticaseibacillus paracasei GMNL⁃653 ameliorates human scalp health by regulating scalp microbiome［J］. BMC Microbiol, 2023,23（1）:121. doi: 10.1186/s12866⁃023⁃02870⁃5.
［37］	Raymond O, Abidi Z, Pannu S, et al. 44105 Hydradermabrasion treatment outcomes in a pediatric and adult patient with seborrheic dermatitis［J］. Journal of the American Academy of Dermatology, 2023,89（3）:AB174. doi: 10.1016/j.jaad.2023. 07.696.
［38］	Liu J, Han C, Feng X, et al. Effective picosecond Nd:YAG laser on seborrheic dermatitis and its mechanism［J］. J Cosmet Dermatol, 2022,21（6）:2449⁃2457. doi: 10.1111/jocd.14414.
［39］	Choi YG, Kim SY, Kim JS, et al. Efficacy and safety of precision cryotherapy to treat seborrheic dermatitis of the scalp［J］. Dermatol Surg, 2024,50（1）:47⁃51. doi: 10.1097/DSS.00000000 00003960.
［40］	Fonseka S, Narankotuwa K, Bandara D. Light⁃emitting diode light therapy for facial seborrhoeic dermatitis: a case report［J］. J Cutan Aesthet Surg, 2021,14（2）:241⁃243. doi: 10.4103/JCAS.JCAS_188_20.
［41］	中华医学会皮肤性病学分会, 中国医师协会皮肤科医师分会, 中国中西医结合学会皮肤性病专业委员会. 中国化学剥脱术临床应用专家共识（2022）［J］. 中华皮肤科杂志, 2022,55（11）:949⁃955. doi: 10.35541/cjd.20220309.
［42］	Gu RL, Wang SQ. Clinical study on treatment of facial seborrheic dermatitis with intense pulsed light combined with 30% supramolecular salicylic acid［J］. Clinics （Sao Paulo）, 2020,75:e1875. doi: 10.6061/clinics/2020/e1875.
［43］	邓涵, 张旭冉, 方蕊馨, 等. 复合酸治疗头皮脂溢性皮炎的临床疗效研究［J］. 中国医疗美容, 2023,13（9）:37⁃41. doi: 10. 19593/j.issn.2095⁃0721.2023.09.011.

[1]	Chen Haotian, Liu Lian, Zhang Ting, Liu Qingfeng, Li Xiaoxue, Diao Ping, Jiang Xian. Port-wine stains: mechanisms underlying the development and progression [J]. Chinese Journal of Dermatology, 2024, 57(7): 661-664.
[2]	Jiang Xian, Liu Lian, Zhang Ting. Treatment of port-wine stains: current status and prospects [J]. Chinese Journal of Dermatology, 2024, 57(7): 590-594.
[3]	Feng Mengdi, Wang Wenqing. Regulatory roles of transcription factors and receptors in the pathogenesis of acne [J]. Chinese Journal of Dermatology, 2024, 57(6): 575-578.
[4]	China Dermatologist Association. Guidelines for the management of chronic pruritus （2024） [J]. Chinese Journal of Dermatology, 2024, 57(5): 387-399.
[5]	Yan Rufan, Liao Jieyue, Guo Ziyu, Yao Nan, Zhou Wenyu, Luo Shuaihantian, Zhang Guiying, Zhao Ming. Pathogenesis and targeted therapy of pemphigus [J]. Chinese Journal of Dermatology, 2024, 57(4): 374-378.
[6]	Ju Qiang, Li Jiaqi. Acne vulgaris revisited: from pathogenesis to treatment strategies [J]. Chinese Journal of Dermatology, 2024, 57(4): 289-294.
[7]	Zong Yangyongyi, Ma Chujun, Su Zhonglan. Eczematization following the treatment of psoriasis with biological agents: pathogenesis and management [J]. Chinese Journal of Dermatology, 2024, 0(3): 20220578-e20220578.
[8]	Liu Tingwei, Meng Xiaoqi, Gu Duoduo, Pan Ruoxin, Zhang Yue, Xu Yang. Advances in the pathogenesis of rosacea [J]. Chinese Journal of Dermatology, 2024, 57(2): 186-190.
[9]	Mycobacteriosis Research Group, China " Belt and Road " Dermatology Alliance, Division of Dermatology and STI Diagnosis, Chinese Association on Leprosy. Expert consensus on the diagnosis and treatment of cutaneous nontuberculous mycobacterial diseases in China （2024） [J]. Chinese Journal of Dermatology, 2024, 57(2): 109-118.
[10]	Chinese Society of Dermatology, China Dermatologist Association, Dermatology & Venereology Specialized Committee of Chinese Association of Integrative Medicine. Guidelines for the treatment of psoriasis with biologics and small-molecule drugs in China （2024） [J]. Chinese Journal of Dermatology, 2024, 57(11): 976-997.
[11]	Song Zhiqiang, Chen Qiquan, Ge Lan. Insights into the progress in targeted therapy of atopic dermatitis from the perspective of its pathogenesis [J]. Chinese Journal of Dermatology, 2023, 56(8): 718-723.
[12]	Liang Yunsheng, Li Zhanhong, Wu Yibei. Progress in the treatment of chronic spontaneous urticaria: insights from the changes in the understanding of its pathogenesis [J]. Chinese Journal of Dermatology, 2023, 56(6): 552-558.
[13]	Wang Li, Wang Qianqiu, Zhang Ruili. Research progress in latent syphilis [J]. Chinese Journal of Dermatology, 2023, 0(2): 20220283-e20220283.
[14]	Ding Meilin, Li Hongyang, Zhang Wei, Zeng Xuesi. Pathogenesis of extramammary Paget′s disease [J]. Chinese Journal of Dermatology, 2023, 0(2): 20220588-e20220588.
[15]	Jiang Jiayi, Wang Daguang. Pathogenesis of nail damages secondary to systemic diseases [J]. Chinese Journal of Dermatology, 2023, 0(2): 20220078-e20220078.

Pathogenesis and treatment of seborrheic dermatitis

PDF

Knowledge

Abstract

Cite this article

share this article

References ［43］

Related Articles 15

Metrics

Comments

Recommended 10